Jeffrey Schneider, MD
Interventional Pain Medicine · Havre de Grace, MDNPI 1700032711
Payments from drug & device makers
Across 486 payments — averaging $19.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Abbott$850
- Pfizer$837
- Lundbeck LLC$528
- Averitas Pharma Inc.$417
- Collegium Pharmaceutical, Inc.$394
- plus $4K from 44 others
What the payments were for
- Food & beverage$9,285100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Proclaim Family of SCS IPGs$300
- Vascepa$125
- UBRELVY$110
How this compares
$9,285 in reported general payments places this provider in the 70th percentile of 56 interventional pain medicine providers in Maryland.
See all interventional pain medicine providers in Maryland →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OxycontinOxycodone Hcl | 14 | $3,390 |
| Pregabalin | 85 | $1,268 |
| Oxycodone Hcl | 80 | $978 |
| Gabapentin | 58 | $768 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $682 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $408 |
| Morphine Sulfate ErMorphine Sulfate | 25 | $346 |
| Tramadol Hcl | 35 | $196 |
| Diclofenac Sodium | 24 | $178 |
| Buspirone Hcl | 18 | $156 |
| Cyclobenzaprine Hcl | 11 | $138 |
| Diazepam | 26 | $27 |
| Prednisone | 13 | $13 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Havre de Grace
- Mark ColemanPikesville$1.3M
- Marc LoevRockville$318K
- Anish PatelFrederick$311K
- Aneesh SinglaSalisbury$167K
- Charles SimmonsAnnapolis$73K
- Ali El-MohandesHagerstown$57K
- Michael WongBel Air$31K
- Anna IrwinBethesda$30K
- Dontese NicholsonBaltimore$27K
- Rajesh JariNottingham$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.